Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3436 AL 3450

Current Insights of Nanocarrier-Mediated Gene Therapeutics to Treat Potential Impairment of Amyloid Beta Protein and Tau Protein in Alzheimer's Disease

Jain U, Johari S, Srivastava P.

Mol Neurobiol. 2024 Apr;61(4):1969-1989. doi: 10.1007/s12035-023-03671-7. Epub 2023 Oct 13.

Donanemab: Not two without a third

Kurkinen M.

Adv Clin Exp Med. 2023 Oct;32(10):1085-1087. doi: 10.17219/acem/172673.

Role of diet and exercise in aging, Alzheimer's disease, and other chronic diseases

Khemka S, Reddy A, Garcia RI, Jacobs M, Reddy RP, Roghani AK, Pattoor V, Basu T, Sehar U, Reddy PH.

Ageing Res Rev. 2023 Nov;91:102091. doi: 10.1016/j.arr.2023.102091. Epub 2023 Oct 11.

Memantine: Updating a rare success story in pro-cognitive therapeutics

Karimi Tari P, Parsons CG, Collingridge GL, Rammes G.

Neuropharmacology. 2024 Feb 15;244:109737. doi: 10.1016/j.neuropharm.2023.109737. Epub 2023 Oct 11.

Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus

Veselov IM, Vinogradova DV, Maltsev AV, Shevtsov PN, Spirkova EA, Bachurin SO, Shevtsova EF.

Int J Mol Sci. 2023 Sep 22;24(19):14450. doi: 10.3390/ijms241914450.

Anti-Amyloid Therapies for Alzheimer's Disease and the Amyloid Cascade Hypothesis

Fedele E.

Int J Mol Sci. 2023 Sep 24;24(19):14499. doi: 10.3390/ijms241914499.

The Role of Adipokines in the Pathologies of the Central Nervous System

Huber K, Szerenos E, Lewandowski D, Toczylowski K, Sulik A.

Int J Mol Sci. 2023 Sep 28;24(19):14684. doi: 10.3390/ijms241914684.

Physical Exercise as Disease-Modifying Alternative against Alzheimer's Disease: A Gut-Muscle-Brain Partnership

Cutuli D, Decandia D, Giacovazzo G, Coccurello R.

Int J Mol Sci. 2023 Sep 28;24(19):14686. doi: 10.3390/ijms241914686.

Amyloid Precursor Protein and Alzheimer's Disease

Orobets KS, Karamyshev AL.

Int J Mol Sci. 2023 Sep 30;24(19):14794. doi: 10.3390/ijms241914794.

Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension

Hu J, Sha W, Yuan S, Wu J, Huang Y.

Int J Mol Sci. 2023 Oct 9;24(19):15023. doi: 10.3390/ijms241915023.

Small molecules targeting molecular chaperones for tau regulation: Achievements and challenges

He C, Gu J, Wang D, Wang K, Wang Y, You Q, Wang L.

Eur J Med Chem. 2023 Dec 5;261:115859. doi: 10.1016/j.ejmech.2023.115859. Epub 2023 Oct 6.

Landscape of Phase II Trials in Alzheimer's Disease

Lee A, Shan D, Castle D, Rajji TK, Ma C.

J Alzheimers Dis. 2023;96(2):745-757. doi: 10.3233/JAD-230660.

Local and long-range GABAergic circuits in hippocampal area CA1 and their link to Alzheimer's disease

Hernández-Frausto M, Bilash OM, Masurkar AV, Basu J.

Front Neural Circuits. 2023 Sep 29;17:1223891. doi: 10.3389/fncir.2023.1223891. eCollection 2023.

The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review

Arjmandi-Rad S, Vestergaard Nieland JD, Goozee KG, Vaseghi S.

Neurol Sci. 2024 Feb;45(2):417-430. doi: 10.1007/s10072-023-07114-y. Epub 2023 Oct 16.

Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer's disease

Chavoshinezhad S, Beirami E, Izadpanah E, Feligioni M, Hassanzadeh K.

Biomed Pharmacother. 2023 Dec;168:115656. doi: 10.1016/j.biopha.2023.115656. Epub 2023 Oct 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias